David Charles Lubner
Director · Braveheart Bio, Inc.
Individual3 10b5-1 trades
- 2025
- Aug 7, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Charles Lubner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- Erez Chimovits - $34.92M in BRVE purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $34.92M in BRVE purchases and sales in the last 12 months
- AH Bio Fund IV, L.P. - $19.80M in BRVE purchases and sales in the last 12 months
- Christopher Viehbacher - $1.50M in BRVE purchases and sales in the last 12 months
- Travis Murdoch - $1.50M in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Charles Lubner?
David Charles Lubner is a corporate insider, tracked as Director of Braveheart Bio, Inc. (BRVE). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Charles Lubner submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Charles Lubner been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1000K) and 1 open-market sale ($450K) across all tracked filings.
